All News
Swimming Reduces Disability from Low Back Pain
EurekAlert!
Swimming is commonly recommended for patients with chronic low back pain. Yet, there is little trial data investigating swimming. An Australian study has shown for the first time that a program of swimming can be clinically effective in reducing disability from chronic low back pain.
Read Article
Evidence-Based Dietary Recommendations for Gout
Gout, historically referred to as the “disease of kings,” was once associated with a lifestyle of excess, including ready access to alcohol and rich meats once reserved for society’s highest ranks.
Read Article
Persistence of education and monitoring is crucial to optimal gout management
It is important that the misconceptions and myths held by the patient are discussed and dispelled and, most importantly, establish a clear understanding of “the plan” and the reason for initiating urate-lowering therapy (ULT).
Read Article
Fibromyalgia: Diagnosis and Management
https://t.co/L9nA1TlJKx https://t.co/G4bkxTsXCt
Dr. John Cush RheumNow ( View Tweet)
EUSTAR scleroderma substudy propensity matched pts Rx w/ JAKi (n 38) vs 180 pts ea Rx w/ MMF, MTX, RTX. 1/3 had dcSSc. 23 AEs in 997 Pt-yrs. JAKi outcomes similar to comparators. JAKi Tx D/C in 39%, FVC stable, skin fibrosis improved (mRSS −1.8) & SJC decreased. No new
Dr. John Cush RheumNow ( View Tweet)
QD Clinic: Gout, Sepsis… or Both?
Dr. Mrinalini Dey, London, discusses a complex case.
https://t.co/UtncfZgZyL https://t.co/xVTA0LnPpN
Dr. John Cush RheumNow ( View Tweet)
The Lancet Rheumatology has a good editorial about the avacopan bad news reports with EMA, FDA and Japan issuing negative opinions that threaten the drugs future. Yet, since approval real world data on avacopan has been favorable w/ less steroid toxicity & most hepatotoxicity https://t.co/k6ebVeWv2K
Dr. John Cush RheumNow ( View Tweet)
"Leeuwenhoek (invented the microscope) examined uric acid (C5H4N4O3) crystals from gout patients and found them to resemble needles. He expounded on his observations in an 11 July 1679 letter responding to an earlier query from Mr. Lambert van Velthuysen (1622–1685), a physician, https://t.co/mY2wqYlRda
Dr. John Cush RheumNow ( View Tweet)
UK primary care database (2000–21) gout study of new colchicine initiators (n 31,478) vs noninitiators (mean 60 yrs, BMI 30), follow-up of 4.5 yrs. Colchicine use had a signif. 12% lower risk of Joint Arthroplasty (HR 0.88); 23% lower TJA in knee/hip OA (HR 0.77) https://t.co/TkYFYhANuH
Dr. John Cush RheumNow ( View Tweet)
QD Clinic: Gout: Is it the Journey or the Destination?
Dr. Arthur Kavanaugh discusses a gout patient whose frequent flares improved after lifestyle changes, despite medication not being enough on its own.
https://t.co/frf4O87L0I https://t.co/cjtiYY9Ayt
Dr. John Cush RheumNow ( View Tweet)
Predicting and Managing Gout Flares in Hospitalized Patients
Dr. Kanon Jatuworapruk, Bangkok, discusses predicting and managing gout flares in hospitalized patients as part of RheumNow's "Gout: More than Flares" campaign in July 2026.
https://t.co/wrLbjsayrI https://t.co/eWmRqPNWsJ
Dr. John Cush RheumNow ( View Tweet)
51 yoM w/ 2 yrs of FUO, unintentional 32-kg wt loss, LN, diffuse myalgias, but no GI Sxs or arthralgia. Neg MRIs, CT, PET scan, EGD, colonoscopy. Abnl labs: CRP 173 mg/L, ESR 46, anemia & ^ WBC. Cell-free DNA next-generation sequencing dx Tropheryma whipplei, & Whipple disease https://t.co/nJLa4l7Ers
Dr. John Cush RheumNow ( View Tweet)
Genetic study of 16 pts w/ Allopurinol-induced severe cutaneous adverse Rxn (SJS/TEN) shows 2 class I alleles to be associated: HLA-B*58:01 (OR, 28.0 [95% CI, 8.6-100.6]) and HLA-A*34:02 (OR, 20.6 [95% CI, 3.3-131.1]). Both explain 80% risk in US pts https://t.co/OxDXuWCbup https://t.co/oky61JImQV
Dr. John Cush RheumNow ( View Tweet)
Psoriatic Arthritis: EULAR 2026 Recap
https://t.co/tBMu4CEn0o https://t.co/iztShOHxOf
Dr. John Cush RheumNow ( View Tweet)
Seronegative RA Disease Activity (7.17.2026)
Dr. Jack Cush reviews the news, journal articles and Gout features from this past week on RheumNow and check your knowledge in this week's RheumIQ quiz!
https://t.co/e0u9qwtHVi https://t.co/oav00L7Lzw
Dr. John Cush RheumNow ( View Tweet)
2 Still's dz cohorts (96 Shanghai, 28 Erlangen0 compared response to biolgics vs DMARDs (MTX, CNI,JAKi). in 124 AOSD pts, biologic had more sustained event-free remission and event-free state (P 0.0065, P 0.0096) & more steroid D/C vs MTX/CNI (p < 0.05). https://t.co/lJaI9nhPYr
Dr. John Cush RheumNow ( View Tweet)
ACR: Medicare Cuts for Physicians Highlight Need for Reform
The ACR was disappointed that the proposed MPFS from the CMS once again included a serious cut to the conversion factor. The -1.68% cut would lower reimbursement to physicians providing care to Medicare beneficiaries https://t.co/PmAmFPnw6R
Dr. John Cush RheumNow ( View Tweet)
Gout patients are at greater risk for dementia, sleep apnea, septic arthritis and erectile dysfunction.
For more gout content, follow our Gout: More than Flares campaign at https://t.co/lQoiFjubZJ, https://t.co/p4WQ1GCB68
Dr. John Cush RheumNow ( View Tweet)
The Marriage between Gout and the Kidney
While the link between uric acid and gout was first described by Alfred Baring Garrod in the 1800s, the proof that uric acid might actually be the cause had to await the self-experimentation of two rheumatologists from the University of https://t.co/AWZbjaUtdu
Dr. John Cush RheumNow ( View Tweet)
